Beverly Hills, CANCT06990269Now EnrollingIRB Ready

Geographic Atrophy Secondary to Age-related Macular Degeneration Clinical Trial in Beverly Hills, CA

Access cutting-edge geographic atrophy secondary to age-related macular degeneration treatment through this clinical trial at a research site in Beverly Hills. Study-provided care at no cost to qualified participants.

Sponsored by ADARx Pharmaceuticals, Inc.

Quick Self-Assessment

See if you qualify for this Beverly Hills location

Preparing your pre-screening questions…

Expert Care in Beverly Hills

Access geographic atrophy secondary to age-related macular degeneration specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related geographic atrophy secondary to age-related macular degeneration treatment provided free

Apply for This Beverly Hills Location

Check if you qualify for this geographic atrophy secondary to age-related macular degeneration clinical trial in Beverly Hills, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Beverly Hills

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Beverly Hills site if eligible
  4. 4Begin participation

About This Geographic Atrophy Secondary to Age-related Macular Degeneration Study in Beverly Hills

Phase 2 study is designed to assess the efficacy of ADX-038 compared with placebo in participants with GA secondary to AMD. Safety, pharmacokinetics (PK), and pharmacodynamics (PD) will also be assessed.

Sponsor: ADARx Pharmaceuticals, Inc.

Who Can Participate

Inclusion Criteria

Clinical diagnosis of GA of the macula secondary to AMD
GA lesions between 2.5 and 12.5 mm2 at screening
Sufficiently clear ocular media, adequate pupillary dilation and fixation to permit quality fundus imaging in the study eye as described in the protocol
Willing and able to comply with clinic visits and study-related procedures, including completion of the full series of meningococcal vaccinations and pneumococcal vaccination required per protocol

Exclusion Criteria

Has GA secondary to causes other than AMD
Has active ocular disease that compromises or confounds visual function
History of surgery for retinal detachment
Has ocular condition other than GA secondary to AMD
Use of intravitreal complement inhibitors in study eye
Hereditary or acquired complement deficiency
Active viral, bacterial or fungal infection
Liver injury as evidenced by abnormal liver function tests
Donating blood
History of choroidal neovascularization in the study eye

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Beverly Hills?

Yes, this clinical trial (NCT06990269) has an active research site in Beverly Hills, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Geographic Atrophy Secondary to Age-related Macular Degeneration Treatment Options in Beverly Hills, CA

If you're searching for geographic atrophy secondary to age-related macular degeneration treatment options in Beverly Hills, CA, this clinical trial (NCT06990269) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Beverly Hills research site is actively enrolling participants for this clinical trial. You'll receive care from experienced geographic atrophy secondary to age-related macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all geographic atrophy secondary to age-related macular degeneration clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Beverly Hills, CA

See all rheumatoid arthritis clinical trials recruiting in Beverly Hills — not just this study.

Browse Rheumatoid Arthritis Trials in Beverly Hills

Ready to Join in Beverly Hills?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Beverly Hills, CA